Vanta Bioscience Share Price History and Returns 2017 to 2024
Vanta Bioscience Limited | |||
 | Price: ₹42.47 | ||
| 52 Week Low: ₹37.01 52 Week High: ₹101.64 | |||
| Market Capital: 44.18 Crore (Smallcap) | |||
| -> | |||
Show Table of Contents
Table of Contents
- 1: Vanta Bioscience Stock Highlights
- 1.1: 52-Week High Low
- 1.2: All Time High
- 2: Vanta Bioscience Recent Performance
- 3: Vanta Bioscience Stock Price Chart From 2017 to 2024
- 4: Vanta Bioscience Stock Price History Table From 2017 to 2024
- 5: Analyzing the Impact of Investing in Vanta Bioscience
- 5.1: Vanta Bioscience Stock Returns In Last 5 Years
- 6: Vanta Bioscience Returns vs Bank FD Returns
Vanta Bioscience Stock Highlights
As of 24 Dec 2024, Vanta Bioscience Stock price is ₹42.47 which is ₹59.17 below 52-week high of ₹101.64 and ₹5.46 above 52-week low of ₹37.01
52-Week High Low
- Vanta Bioscience 52-Week High is ₹101.64 occurred on 29 Feb 2024
- Vanta Bioscience 52-Week Low is ₹37.01 occurred on 23 Oct 2024
All Time High
- The all-time high or the highest price that Vanta Bioscience stocks have ever touched was ₹195.50 and this occurred on 01 Mar 2021.
- The highest closing price at which Vanta Bioscience stocks have ever closed was ₹193.00 recorded on 01 Apr 2019.
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Vanta Bioscience Recent Performance
Over the past 15 trading days, the value of Vanta Bioscience's stock has decreased by ₹5.35 (-11.19%). On 04 Dec 2024, its one share was worth ₹47.82 and by 24 Dec 2024, the value dropped to ₹42.47. During this period it created a highest high of ₹49.86 and lowest low of ₹38.45.
Click on legend items to show/hide respective price lines
Vanta Bioscience Stock Price Chart From 2017 to 2024
Click on legend items to show/hide respective price lines
Vanta Bioscience Stock Price History Table From 2017 to 2024
| Year | Vanta Bioscience | YOY Chg% | ↑High - ↓Low |
|---|---|---|---|
| 2024 | ₹42.47 | -20.7% | ↑ ₹50.33 ↓ ₹38.45 |
| 2023 | ₹53.55 | -15.9% | ↑ ₹76.70 ↓ ₹37.00 |
| 2022 | ₹63.65 | -49.8% | ↑ ₹189.00 ↓ ₹60.80 |
| 2021 | ₹126.75 | -2.5% | ↑ ₹195.00 ↓ ₹105.00 |
| 2020 | ₹130.00 | 17.3% | ↑ ₹190.00 ↓ ₹80.00 |
| 2019 | ₹110.80 | 30.8% | ↑ ₹195.00 ↓ ₹82.00 |
| 2018 | ₹84.65 | 24.9% | ↑ ₹114.00 ↓ ₹46.00 |
| 2017 | ₹67.75 | - | ↑ ₹73.95 ↓ ₹41.40 |
Analyzing the Impact of Investing in Vanta Bioscience
Vanta Bioscience Stock price in the year 2017 was ₹67.75. If you had invested ₹10,000 in Vanta Bioscience Stock in 2017, in 7 years, your investment would have reduced to ₹6,268 by the end of 2024. This represents a negative return of -37.4% from 2017 to 2024, with a compound annual growth rate (CAGR) of -6.5%.
Vanta Bioscience Stock Returns In Last 5 Years
- Its highest stock price in the last 5 years was: ₹195.50 and lowest was: ₹37.00
- Vanta Bioscience Stock price in 2019 was ₹110.80
- By 2024, its stock price dropped to ₹42.47
- It gave a negative return of over -61.7% with a CAGR of -17.5% over the last 5 years
- If you had invested ₹10,000 in Vanta Bioscience in 2019 then in 5 years, your investment would have declined to ₹3,833.03 by 2024.
Vanta Bioscience Returns vs Bank FD Returns
| Investment Type | Initial Amount | Final Value | Total Returns |
|---|---|---|---|
| Vanta Bioscience Shares | ₹10,000 | ₹6,268.63 | -37.3% |
| Bank FD (Simple Interest) | ₹10,000 | ₹14,200 | 42.0% |
| Bank FD (Compound Interest) | ₹10,000 | ₹15,036.3 | 50.4% |
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
